Traders Buy Shares of Humana Inc. (HUM) on Weakness

Traders purchased shares of Humana Inc. (NYSE:HUM) on weakness during trading on Wednesday. $71.39 million flowed into the stock on the tick-up and $34.96 million flowed out of the stock on the tick-down, for a money net flow of $36.43 million into the stock. Of all stocks tracked, Humana had the 18th highest net in-flow for the day. Humana traded down ($0.11) for the day and closed at $240.38

HUM has been the subject of a number of recent analyst reports. Piper Jaffray Companies reiterated a “buy” rating and issued a $246.00 price objective on shares of Humana in a report on Friday, July 14th. Cowen and Company reiterated a “buy” rating and issued a $230.00 price objective on shares of Humana in a report on Friday, July 14th. Bank of America Corporation upped their price objective on Humana from $270.00 to $275.00 and gave the company a “buy” rating in a report on Friday, July 14th. Citigroup Inc. initiated coverage on Humana in a report on Wednesday, June 28th. They issued a “buy” rating and a $275.00 price objective for the company. Finally, BidaskClub upgraded Humana from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Eleven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $251.60.

The firm has a market capitalization of $34.74 billion, a PE ratio of 19.77 and a beta of 0.86. The stock’s 50-day moving average price is $248.64 and its 200-day moving average price is $235.08.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the company posted $2.30 EPS. Equities analysts predict that Humana Inc. will post $11.56 EPS for the current year.

The firm also recently disclosed a dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 29th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.06%.

In related news, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the completion of the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP M Todoroff Christopher sold 22,935 shares of the business’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $252.52, for a total value of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,595 shares of company stock valued at $14,133,706. Corporate insiders own 0.80% of the company’s stock.

A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. increased its position in Humana by 2,281.7% in the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares in the last quarter. Vanguard Group Inc. increased its position in Humana by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock valued at $2,380,366,000 after buying an additional 157,868 shares in the last quarter. FMR LLC increased its position in Humana by 29.3% in the 2nd quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock valued at $1,571,264,000 after buying an additional 1,479,210 shares in the last quarter. State Street Corp increased its position in Humana by 1.4% in the 1st quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock valued at $1,293,487,000 after buying an additional 84,716 shares in the last quarter. Finally, Capital Research Global Investors increased its position in Humana by 9.7% in the 2nd quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock valued at $940,182,000 after buying an additional 346,069 shares in the last quarter. 95.12% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://transcriptdaily.com/2017/10/12/traders-buy-shares-of-humana-inc-hum-on-weakness.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply